WHO calls for action to support adolescent mental and sexual health

Increased investment is urgently needed to address evolving health risks and meet the mental and sexual and reproductive health needs for the nearly 1.3 billion adolescents (aged 10-19 years) globally, according to a new scientific publication released by the World Health Organization (WHO).

Insilico Medicine Launches First-in-Human Trial for AI-Discovered IBD Drug

What You Should Know: Insilico Medicine (“Insilico”), a generative artificial intelligence (AI)-driven clinical-stage biotechnology company, today announced that the company has initiated the first-in-human study

December 8, 2023

Verastem Oncology submits NDA for ovarian cancer treatment

Verastem initiated the rolling NDA submission in May. Credit: Jo Panuwat D via Shutterstock. Verastem Oncology has concluded the rolling submission of a new drug

November 1, 2024

PharmAla and Red Light Holland to Collaborate on Medical Psilocybin Development | Psychedelic Invest

VANCOUVER, British Columbia, Feb. 09, 2024 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development,

February 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.